Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products.
Business Segments
The company operates through several business segments, each contributing to the company’s overall growth and value creation. The company’s primary bu…
Analysis
Deep value
Daiichi Sankyo Company, Limited lands in the deep-value zone: the price is very low, but so are the business fundamentals. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is fair. You pay 20.4× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 6% yearly growth; analysts expect 11%. The price, in other words, assumes less than the experts do.
The trajectory is tepid and the balance sheet is sturdy. The company scores 14/20 on our value-creation score: strong value creator.
What to watch: Some accounting patterns deserve a closer look. Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202335
79
2023202420252026
All-time high
89
Mar 2026
All-time low
33
Jun 2023
Average rank
72
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
40
31
24
28
Price/Earnings
40
37
17
12
Price/Book
25
23
18
28
Dividend Yield
93
55
41
28
Value (overall)
41
26
16
15
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.